Cita APA (7a ed.)

(2017). Treatment with a new peroxisome proliferator-activated receptor gamma agonist, pyridinecarboxylic acid derivative, increases angiogenesis and reduces inflammatory mediators in the heart of Trypanosoma cruzi-infected mice.

Cita Chicago Style (17a ed.)

Treatment with a New Peroxisome Proliferator-activated Receptor Gamma Agonist, Pyridinecarboxylic Acid Derivative, Increases Angiogenesis and Reduces Inflammatory Mediators in the Heart of Trypanosoma Cruzi-infected Mice. 2017.

Cita MLA (8a ed.)

Treatment with a New Peroxisome Proliferator-activated Receptor Gamma Agonist, Pyridinecarboxylic Acid Derivative, Increases Angiogenesis and Reduces Inflammatory Mediators in the Heart of Trypanosoma Cruzi-infected Mice. 2017.